R. Batteson
R. Batteson publishes mostly in Economics and Econometrics, Oncology and Pulmonary and Respiratory Medicine, on topics such as Health Systems, Economic Evaluations, Quality of Life, Cancer Immunotherapy and Biomarkers and Lung Cancer Treatments and Mutations.
- World rank
- #5,437,547 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #318,193 of 367,258
- Works
- 18
- Citations
- 54
- Citations per work
- 3.0
What does R. Batteson research?
R. Batteson's work is mostly in Medicine (43%), Economics, Econometrics and Finance (26%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences843.1%
- Medicine843.1%
- Social Sciences525.5%
- Everything else423.6%
- Life Sciences17.8%
- 1Economics and Econometrics26% of their works
- 2Oncology22% of their works
- 3Pulmonary and Respiratory Medicine14% of their works
- 4Surgery8% of their works
- 5Cancer Research4% of their works
- 6Immunology4% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Economic and Financial Impacts of Cancer
- Cancer Genomics and Diagnostics
- Biosimilars and Bioanalytical Methods
- Mathematical Biology Tumor Growth
- Colorectal Cancer Treatments and Studies
Which keywords describe R. Batteson's research?
The keywords of their largest research topics: Cost-effectiveness Analysis, Quality of Life, Immune Checkpoint Blockade, PD-1 and PD-L1, Targeted Therapy, ALK Inhibitors, EGFR Mutations and Cost of Care.
- Mathematical Modeling
- Immunogenicity
- Cancer Growth
- Biosimilars
- Cost of Care
- ALK Inhibitors
- PD-1 and PD-L1
- Quality of Life
- Cost-effectiveness Analysis
- Immune Checkpoint Blockade
- Targeted Therapy
- EGFR Mutations
- Financial Toxicity
- Cancer Genomics
- Cetuximab
- KRAS Mutations
- Mutational Signatures
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Cost-effectiveness Analysis101 topic
- Quality of Life101 topic
- Immune Checkpoint Blockade71 topic
- PD-1 and PD-L171 topic
- Targeted Therapy72 topics
- ALK Inhibitors51 topic
- EGFR Mutations51 topic
- Cost of Care31 topic
- Financial Toxicity31 topic
- Biosimilars21 topic
- Cancer Genomics21 topic
- Cancer Growth21 topic
- Cetuximab21 topic
- Immunogenicity21 topic
- KRAS Mutations21 topic
- Mathematical Modeling21 topic
- Mutational Signatures21 topic
Where does R. Batteson work?
R. Batteson's main affiliation in the publication record is BresMed, United Kingdom.
How many publications and citations does R. Batteson have?
OpenAlex counts 18 works and 54 citations for R. Batteson, an h-index of 3, ranking #5,437,547 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about R. Batteson. Posts are plain text and can be reported.